Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

Use of PuraStat Following Aquablation to Determine if There is Change in Hematuria & Probability of Same Day Discharge

NCT: NCT07789041 · RECRUITING

NCT IDNCT07789041
StatusRECRUITING
Start Date2025-08-12
Completion2026-12-12
SponsorEndeavor Health (OTHER)
First posted
Last updated

Brief Summary

Randomized, single-blinded investigational study to assess the safety of PuraStat following the Aquablation procedure

Frequently Asked Questions

What is Use of PuraStat Following Aquablation to Determine if There is Change in Hematuria & Probability of Same Day Discharge?

Use of PuraStat Following Aquablation to Determine if There is Change in Hematuria & Probability of Same Day Discharge is a clinical trial registered under NCT07789041. Current status: RECRUITING.

What is the status of NCT07789041?

The current status of NCT07789041 (Use of PuraStat Following Aquablation to Determine if There is Change in Hematuria & Probability of Same Day Discharge) is: RECRUITING.

When did Use of PuraStat Following Aquablation to Determine if There is Change in Hematuria & Probability of Same Day Discharge start?

Use of PuraStat Following Aquablation to Determine if There is Change in Hematuria & Probability of Same Day Discharge started on 2025-08-12.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.

↑